Eukaryotic ribosomal decoding-site RNA (18S rRNA A-site)

The eukaryotic ribosomal decoding-site RNA is a specialized region within the 18S ribosomal RNA of the small (40S) ribosomal subunit that is fundamental to the accuracy of protein synthesis. It functions as the primary site for monitoring the base-pairing between the mRNA codon and the tRNA anticodon, ensuring that only the correct amino acids are added to the nascent polypeptide chain (Prokhorova et al., 2017). In pharmacological research, this site is a major target for nonsense suppression therapy, which aims to treat genetic disorders caused by premature termination codons (PTCs). Small molecules such as aminoglycosides and Ataluren bind to this decoding center to induce a conformational change that allows the ribosome to misread a stop codon as a sense codon, thereby restoring the production of full-length, functional proteins (Welch et al., 2007). This therapeutic approach is currently being investigated for conditions like Duchenne muscular dystrophy and cystic fibrosis, where nonsense mutations account for a significant portion of cases. However, the clinical utility of targeting the eukaryotic decoding site is often limited by the narrow therapeutic window and potential for systemic toxicity, particularly affecting the kidneys and inner ear (Finkel, 2010). Ongoing drug development focuses on creating synthetic aminoglycosides, such as ELX-02, which are designed to maximize read-through efficiency while minimizing off-target effects on mitochondrial ribosomes and normal termination sites.

Other names

Eukaryotic A-site18S ribosomal RNA decoding regionSmall ribosomal subunit decoding siteEukaryotic decoding centerDecoding site of the 40S ribosomal subunit

Induction of translational read-through of premature stop codons (nonsense suppression) by binding to the decoding center and reducing the stringency of codon-anticodon recognition (Linde and Kerem, 2008).